NEW ORLEANS, Nov. 9 – A small study of patients with heart failure not caused by blocked arteries indicates that women, as well as men, may benefit from implantable cardioverter-defibrillators (ICD) ...

"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...

Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care -- although a ...

Improvements in optimal medical therapy for patients with heart failure with reduced ejection fraction (HFrEF) have helped reduce the risk of sudden cardiac death (SCD)—in the modern era, though, just ...

Study finds no difference in all-cause mortality among patients with chronic kidney disease and heart failure who received implantable cardioverter defibrillators and those who did not. Research has ...

FALLS CHURCH, VA — A new meta-analysis supports the value of an implantable cardioverter defibrillator (ICD) for primary prevention in patients with ischemic and nonischemic cardiomyopathy [1]. When ...

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success DUBLIN and BARCELONA, ...

Although recent studies have proved that implantable cardioverter-defibrillators (ICDs) can prevent sudden cardiac death (SCD) in patients with arrhythmogenic right ventricular dysplasia (ARVD), the ...

The 118 patients considered in this study comprised an arm of a single-blind, randomized, crossover study of 269 patients enrolled in 60 centers and followed up for 6 months. [5] All patients had a ...